Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
David Scott Jones currently holds 5,000 shares of EyePoint Pharmaceuticals, Inc. (EYPT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David Scott Jones has been a net seller of EYPT stock. They have purchased $0 and sold $1.8M worth of shares.
David Scott Jones's most recent insider trade was on Feb 9, 2024, when they sold 4,967 shares at $0.00 per share.
David Scott Jones serves as Executive at EyePoint Pharmaceuticals, Inc. (EYPT). They have executed 56 insider transactions totaling $1.8M over their tenure at the company.
David Scott Jones holds the position of Executive at EyePoint Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 6 years and currently hold a stake valued at $0.
David Scott Jones has shown a selling trading pattern, with $0 in total purchases and $1.8M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by David Scott Jones was on Jan 22, 2024, when they sold $652.3K worth of EYPT shares. This transaction involved 28,750 shares at $22.69 per share.
David Scott Jones currently owns 5,000 shares of EyePoint Pharmaceuticals, Inc. (EYPT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of David Scott Jones's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. David Scott Jones has 56 Form 4 filings on record as an insider at EyePoint Pharmaceuticals, Inc..
Set alerts for David Scott Jones and 40,000+ other insiders.